Abstract
In the multifactorial pathogenesis of atherosclerosis (the W.H.O. gives a list of about forty risk factors) recent acquisitions have allowed to determine in part the role carried out by the term “haemocoagulative disorders” (90) showing the possible connections between haematic components of haemocoagulation and vascular wall that up to now have been only hypothesised.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
U. Abilgaard, Inhibition of the thrombin-fibrinogen reaction by antithrombin III studied by N-terminal analysis. Scand. J. Clin. Lab. Inv. 20:205 (1967).
U. Abilgaard, Inhibition of the thrombin-fibrinogen reaction by alpha 2-macroglobulin, studied by N-terminal analysis. Thromb. Diath. Haemorrh. 21:173 (1968).
L.O. Almer, I.M. Nilsson, On fibrinolysis in diabetes mellitus. Acta Med. Scand. 198:101 (1975).
H.N. Antoniades, C.D. Scher, Growth factor derived from human serum, human platelets and human pituitary: properties and immunological cross reactivity. J. Natl. Cancer Institute p. 137 (1978).
G. Avellone, V. Mandalà, G. Raneli, Coagulazione, aggregazione piastrinica, fibrinolisi in pazienti affetti da arteriopatia ad evoluzione obliterante degli arti inferiori. In: Di Matteo G. & Pola P. (eds.): Atti I Congresso Nazionale della Società Italiana di Patologia Vasculare, p. 231, ERRE.DI.E., Roma, 1979.
G. Avellone, S. Novo, G. Davì, G. Abruzzese, Plasmatic fibrinogen, plasminogen and antithrombin III levels in atherosclerotic patients. In: Strano A. (ed.): Proceedings of European Symposium on advances in coagulation, fibrinolysis, platelet aggregation and atherosclerosis, p. 183, C.E.P.I., Roma, 1978.
G. Avellone, V. Mandalà, F.P. Riolo, A. Pinto, Antithrombin III in patients with atherosclerotic vascular disease. Abstracts of: First International “Colloquy” of Angiology, p. 271, Firenze, 1979.
N.U. Bang, M.L. Chang, Soluble Fibrin complexes. Sem. Thromb. Haemostas. 1:91 (1974).
D. Bensoussan, S. Levi-Toledano, P. Passa, Platelet hyperaggregation in increased plasma level of von Willebrand factor in diabetics with retinopathy. Diabetologia 11:307 (1975).
R. Biggs, K.W.E. Denson, N. Alkman, R. Barrett, M. Hadden, Antithrombin III, antifactor Xa and heparin. Br. J. Haematol. 19:283 (1970).
R. Biggs, The absorption of human F. VIII neutralising antibody by factor VIII. Br. J. Haematol. 26:259–268 (1974).
T.K. Bills, J.B. Smith, M.J. Silver, Metabolism of (14C) arachidonic acid by human platelets. Biochim. Biophys. Acta 124: 303 (1976).
A.L. Bloom, J.C. Giddings, G.R. Peake, Low molecular weight factor VIII. Lancet 1:661–662 (1973).
A.L. Bloom, G.R. Peake, J.C. Giddings, The presence and reactions of high and lower molecular weight procoagulant F.VIII in the plasma of patients with von Willebrand disease after treatment; significance for a structural hypothesis for F.VIII. Thromb. Res. 3:389–404 (1973).
A.L. Bloom, S.C. Giddings, C.J. Wilks, Factor VIII on vascular intima: possible importance in hemostasis and thrombosis. Nature. New Biology 241:217 (1973).
B. Boneu, M. Abbal, J. Plante, R. Bierme, Factor VIII complex and endothelial damage. Lancet 1:1430 (1975).
B. Boneu, D. Durand, F. Counillan, J.P. Charlet, R. Bierme, J.M. Sue, Increased level of factor VIII complex in severe arterial hypertension. Haemostasis 7:332 (1978).
B.N. Bouma, J.M. Hordijk-Hoss, S. De Graaf, J.J. Sixma, J.A. Van Mourik, Presence of factor VIII related antigen in blood platelets of patients with von Willebrand’s disease. Nature 257:510 (1975).
C. Busch, J. Dawes, D.S. Pepper, A. Wasteson, Binding of platelet factor 4 to cultured human endothelial cells. Thrombos. Haemostas. 42:43 (1979).
C. Cavallero, Modificazioni della parete arteriosa nell’arteriosclerosi. In: Cardiología Oggi, vol. 1, p. 193, Ed. Med. Scient., Torino 1975.
A.B. Chandler, Thrombosis and the development of atherosclerosis lesion. In: Jones R. (ed.): Atherosclerosis, p. 88, Springer, New York, 1970.
A.B. Chandler, I. Chapman, L.R. Erhardt, W.C. Roberts, J.C. Schwartz, D. Sinapius, D.M. Spain, S. Sherry, P.M. Neiss, T.L. Simon, Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am. J. Cardiol. 34:823 (1974).
P.S. Damus, M. Hicks, R.D. Rosenberg, A generalized view of heparin’s anticoagulatnt action. Nature 246:355 (1973).
M.J. Davies, N. Woolf, J.W.P. Bradley, Endothelialisation of experimentally produced mural thrombi in the pig aorta. J. Pathol. 97:589 (1969).
K.W.E. Denson, Reagents and techniques, In: The treatment of haemophilia and other clotting disorders. Ed. by R. Biggs and R.G. Macfarlane, p. 337. Blackwell Scientific Publication, Oxford 1966.
K.W.E. Denson, Standardization of methods for the determination of factor VIII. Thrombos. Diathes. Haemorrh. Suppl. 43:99 (1971).
K.W.E. Denson, G.I.C. Ingram, Antigen/biologival-activity ratio for factor VIII. Lancet, 1: 1973.
K.W.E. Denson, In: Human blood coagulation, haemostasis and thrombosis. Ed. by: Biggs R., Blackwell Scientific Publications, Oxford-Edinburgh, 1976.
M. Ekberg, I.M. Nilsson, Factor VIII and glomerulonephritis. Lancet 1: 1111 (1975).
A.P. Fletcher, N. Alkjaersig, O. Owens, G. Wolff, J.R. Smith, Blood hypercoagulability, thrombosis and acute myocardial infarction. J. Lab. Clin. Med. 78:798 (1971).
A.P. Fletcher, N. Alkjaersig, Blood screening methods for the diagnosis of venous thrombosis. Milkbank Mem. Fund. Q. 50: 170 (1972).
A. Girolami, A. Sticchi, T. Barbui, G. Bareggi, Factor VIII immunological assay. An evaluation of several methods using whole plasma. Blut. Band XXIX:309 (1974).
H.L. Goldsmith, The flow of model particles and blood cells and its relation to thrombogenesis. In: Spet T.H. (ed.): Progress in haemostasis and thrombosis. Grune and Stratton, New York, 1972.
J. Gormsen, J.D. Nielsen, L.A. Andersen, ADP-induced platelet aggregation in patients with ischemic heart disease and peripheral thrombo-atherosclerosis. Acta Med. Scand. 201: 509 (1977).
J.W. Haerem, Platelets and sudden death. In: Neri Serneri G.G., Mason, D.T. (eds.): Myocardial Infarction. Excerpta Medica, Amsterdam, p. 30, 1979.
M.D. Haust, R.H. Moore, Development of modern theories on tne pathogenesis of atherosclerosis, In: Wissler R.W., Geer J.C. (eds.): The pathogenesis of atherosclerosis, p. 1, Williams & Wilkins, Baltimora 1972.
E.J. Hershgold, A.M. Davison, M.E. Jansgen, Human F. VIII (antihemophilic factor): activation and inactivation by phospho-lipases. J. Lab. Clin. Med. 77:206 (1971).
E.J. Hershgold, A.M. Davison, M.E. Jansgen, Isolation and some clinical properties of human F. VIII J. Lab. Clin. Med. 77: 185 (1971).
H. Holmsen, Prostaglandin endoperoxide-thromboxane synthesis and dense granuli secretion as positive feedback loops in the propagation of platelet responses during “the basic platelet reaction”. Thromb. Haemost. 38:1030 (1977).
P.W. Howie, C.B. Begg, D.W. Purdie, & coll. Use of coagulation tests to predict the clinical progress of pre-eclampsia. Lancet 2:323 (1976).
J. Hudson, W.T.E. McCaughy, Mural thrombosis and atherogenesis in coronary arteries and aorta. An investigation using anti-fibrin and antiplatelet sera. Atherosclerosis 19:543 (1974).
A. Huges, R.S. Tonks, The role of microemboli in the production of carditis in hypersensitivity experiments. J. Path. Bacte-riol. 77:207 (1959).
E.A. Jaffe, L.W. Hoyer, R.L. Nachman, Synthesis of antiemophilic factor antigen by cultured human endothelial cells. J. Clin. Invest. 52:2757 (1973).
E.A. Jaffe, L.W. Hoyer, R.L. Nachman, Synthesis of von Willebrand factor by cultured human endothelial cells. Proc. Natl. Acad. Sci. USA, 7:190 (1974).
E.A. Jaffe, R.L. Nachman, Submit structure of factor VIII antigen synthetized by cultured human endothelial cells. J. Clin. Invest. 56:698 (1975).
E.A. Jaffe, Endothelial cells and the biology of factor VIII. Nature 296:377 (1977).
C.L. Janssen, W.M. van Leuwen, Behaviour of factors V and factor VII during the process of blood coagulation. Scand. J. Haemat. 9:531 (1972).
L. Jorgensen, T. Hovig, H.C. Roswell, J.F. Mustard, Adenosine diphosphate induced platelet aggregation and vascular injury in swine and rabbits. Am. J. Pathol. 61:161 (1970).
L. Jorgensen, M.A. Packham, H.C. Roswell, M.R. Buchanan, J.F. Mustard, Local aortic injury caused by cannulation: increased plasma protein accumulation and thrombosis. Acta Path. Microbiol.Scand. 82:637 (1974).
K.L. Kaplan, H.L. Nossel, M. Drillings, G. Lesznik, Radioim munoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinipeptide A generation. Br. J. Haematol. 38:129 (1978).
M. Kazama, T. Abe, Change of the molecular mass of fibrinogen in circulating blood, as an index of hypercoagulable states. Thromb. Res. 8:(Suppl. II) 133 (1976).
P.E.A. Kernoff, Affinity of factor VIII clotting activity for antigen detectable immunologically. Nature. New Biology 244:148 (1973).
B.A. Kottke, M.T.R. Subbiah, Subject review pathogenesis of atherosclerosis, concepts based on animal models. Mayo Clin. Proc. 53:35 (1978).
J.L. Lane, P. Bird, C.R. Rizza, A new assay for measurement of total progressive antithrombin. Br. J. Haematol. 30:103 (1975).
C.B. Laurell, Quantitative estimation of proteins by elettro-phoresis in agarose gel containing antibodies. Analitical Biochemistry 15:45 (1966).
C.B. Laurell, Electroimmuno assay. Scand. J. Clin. Lab. Invest. 29, suppl. 124:21 (1972).
E.C. Lian, R.R. Minej, D.R. Harnnes, In vitro and in vivo effects of thrombin and plasmin on human factor VIII (AHF). Am. J. Haemat. 1:481 (1976).
C.A. Ludlam, J.D. Cash, Studies on the liberation of betathromboglobulin from human platelets in vitro. Brit. J. Haematol. 33:239 (1976).
C.A. Ludlam, Beta-thromboglobulin. A new diagnostic tool in the diagnosis of hypercoagulability? In: Neri Serneri G.G., Prentice C.R.M. (eds.): Florence Conference on Haemostasis and Thrombosis. Academic Press, London 1977.
P.M. Mannucci, F.I. Pareti, L. Holmberg, I.M. Nilsson, Z.M. Ruggeri, Studies on the prolonged bleeding time in von Willebrand’s disease. J. Lab. Clin. Med., October, 662 (1976).
E.E. Mayne, J.M. Bridges, J.A. Weawer, Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus. Diabetologia. 6:436 (1970).
S. Moore, D.S. Pepper, J.D. Cash, The isolation and characterization of a platelet specific release beta-globulin: beta-thromboglobulin and the detection of antiurokinase and anti-plasmin released from thrombin aggregated washed human platelets. Bioch. Biophys. Acta 379:360 (1975).
M. Moroi, N. Aoki, Inhibition of plasminogen binding to fibrin by alpha-2-plasmin inhibitor. Thromb. Res. 10:851 (1977a).
M. Moroi, N. Aoki, On the interaction of alpha-2-plasmin inhibitor and proteases. Evidence for the formation of a covalent crosslinkage and non-covalent weak bindings between the inhibitor and proteases. Bioch. Biophys. Acta 482:412 (1977b).
R.L. Nachman, E.A. Jaffe, Subcellular platelet factor VIII antigen and von Willebrand factor. J. Exp. Med. 141:1101 (1975).
P. Needleman, P.S. Kulkarni, A. Raz, Coronary tone modulation: formation and actions of prostaglandins endoperoxides and thromboxanes. Science 195:409 (1977).
G.G. Neri Serneri, G.F. Gensini, R. Abbate, D. Prisco, C. Mugnaini, Soluble fibrinogen complexes and platelet aggregates in patients with history of myocardial infarction and chronic cerebrovascular disorders. A rationale for prophylactic therapy. Europ. Symp. on Platelet Aggregation, Coagulation Fibrinolysis and Atherosclerosis. (A. Strano ed.) p. 277, CEPI, Roma, 1976.
G.G. Neri Serneri, R. Abbate, G.F. Gensini, G. Masotti, Aterosclerosi e stati trombofilici. In: Atti dell’Ottantesimo Congresso della Società Italiana di Medicina Interna, p. 427, Pozzi L., Roma, 1979.
G.G. Neri Serneri, Relationships between system and ischaemic heart disease. In: Neri Serneri G.G., Mason T.D. (eds.): Myocardial Infarction. Excerpta Medica, Amsterdam, 1979.
G.G. Neri Serneri, High molecular weight fibrinogen complexes in the assessment of hypercoagulability, In: Neri Serneri G.G., Prentice C.R.M. (eds.) Haemostasis and Thrombosis, p. 211. Academic Press, London 1979.
H.L. Nossel, I. Yudelman, R.E. Canfield, Measurement of fibrino-peptide A in human blood. J. Clin. Invest. 54:43 (1974).
J.R. O’Brien, M.D. Etherington, S. Jamieson, P. Lawford, S.V. Lincoln, N.J. Alkjaersig, Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis. Thromb. Diath. Haemorrh. 34:483 (1975).
M. Pandolfi, L.O. Aimer, L. Holmberg, Increased von Willebrand antiemophylic factor in diabetic retinopathy. Acta Ophtalmol. 52:823 (1974).
F. Panicucci, A. Sacripanti, E. Pinori, M. Vispi, B. Conte, L. Lecchini, Antithrombin III, heparin cofactor and anti-factor Xa in relation to age, sex and pathological conditions. Thromb. Haemost. 42:127 (1979).
S. Renaud, K. Kuba, C. Goulet, Y. Lemire, C. Allard, Relationship between fatty-acid composition of platelets and platelet aggregation in rat and man. Circ. Res. 26:343 (1970).
R.D. Rosenberg, P.S. Damus, The purification and mechanism of action of human antithrombin-heparin cofactor. J. Biol. Chem. 248:6490 (1973).
J.S. Rosenberg P. McKenna, R.D. Rosenberg, Inhibition of human factor IX by human antithrombin-hepatin cofactor. J. Biol. Chem. 250:8883 (1975).
R.D. Rosenberg, G. Armand, L. Lam, Structure-function relationship of heparin species. Proc. Natl. Sci. USA 75:3065 (1978).
R. Ross, J. Glomset, B. Kariya, R. Harker, A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Sci. USA 71:1207 (1974).
R. Ross, J. Glomset, The pathogenesis of atherosclerosis. New Engl. J. Med. 295:369 (1976).
N. Salky, M. Dugdale, Platelet abnormalities in ischaemic heart disease. Am. J. Cardiol. 32:612 (1973).
S.C. Sharma, H.N. Seth, Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in acute myocardial infarction Br. Heart J. 40:526 (1978).
M.J. Silver, T.K. Bills, J.B. Smith, Platelets and prostaglandins: the key role of platelet phospholipase A2 activity. In: De Gaetano G., Garattini S. (eds.): Platelets: A multidisciplinary approach. Raven Press, New York, 1978.
J.B. Smith, C. Ingerirían, M.J. Silver, Persistence of thromboxane A-2 like material and platelet reíase inducing activity in plasma. J. Clin. Inv. 58:1119 (1976).
J. Stibbe, Effect of exercise on F. VIII complex: proportional increase of Ristocetin cofactor (von Willebrand cofactor) and F. VIII AGN, but disproportional increase of F. VIII AHF. Thromb. Res., vol.10:163 (1977).
H. Stormorken, J. Herikssen, S. Nitter-Hange, A. Hellem, Antithrombin III and arterial thromboembolism. In: A. Strano (ed.) Proceedings of European Symposium on Advances in Coagulation, Fibrinolysis, Platelet Aggregation and Atherosclerosis. p. 19, CE.P.I., Roma, 1978.
A. Strano, S. Novo, G. Davi, G. Avellone, A. Pinto, La sindrome trombofilica delle arteriopatie obliteranti degli arti in-feriori. In: Atti dell’Ottantesimo Congresso della Società Italiana di Medicina Interna, p. 535, Pozzi L. Roma, 1979.
A. Strano, S. Novo, Prospettive sull’impiego degli antiaggreganti piastrinici nellTarteriosclerosi. Editoriale Giorn. Ital. Cardiol. 9:1 (1979).
A. Strano, S. Novo, G. Davi, G. Avellone, Fisiopatologia della coagulazione, dell’aggregazione piastrinica nella cardio-patia ischemica. In: Atti del XXXVIII Congresso Nazionale della Società Italiana di Cardiología, suppl. Boll. Soc. Ital. Cardiol., p. 499, Roma, 1980.
T. Strasser, Atherosclerosis and coronary heart disease: the contribution of epidemiology. WHO Chron. 26:7 (1972).
J. Svensson, M. Hamberg, B. Samuelsson, Prostaglandin endo-peroxides IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets. Acta Physiol. Scand. 94:222 (1975).
M.E. Switzer, P.A. McKee, Some effects of calcium on the activation of human factor VIII: von Willebrand factor protein by thrombin. J. Clin. Invest. 60:819 (1977).
A. Teien, V. Abildgaard, M. Höök, The anticoagulant effect of heparin sulphate and dermatan sulphate. Thromb. Res. 8: 859 (1976).
Z.I. Terashita, H. Fukui, K. Nishikawa, M. Hirata, S. Kikuchi, Coronary vasospastic action of thromboxane A2 in isolated working guinea pig hearts. Europ. J. Pharmacol. 53:94 (1978).
C. Thomson, C.D. Forbes, C.R.M. Prentice, Relationship of factor VIII to Ristocetin induced platelet aggregation: effect of heterologous and acquired factor VIII antibodies. Thromb. Res. 3:363 (1973).
J.F. Toole, R. Janeway, K. Choi, R. Cordell, F. Johnston, H.S. Muller, Transient ischemic attacks due to atherosclerosis: a prospective study of 160 patients. Arch. Neurol. 32:5 (1975).
V.T. Turitto, H.R. Baumgartner, Platelet interaction with sub-endothelium in a perfusion system: physical role of red blood cells. Microvasc. Res. 9:335 (1975).
E. von Kaulla, K.N. von Kauila, Antithrombin III and disease. Am. J. Clin. Pathol. 48:69 (1967).
P.N. Walsh, Albumin density gradient and washing of platelets and the study of platelet coagulant activities. Br. J. Haemat. 22:205 (1972).
P.N. Walsh, Platelet coagulant activities and haemostasis: a hypothesis. Blood 43:597 (1974).
H.J. Weiss, L.W. Hoyer, R.F. Rickles, A. Varma, J. Rogers, Quantitative assay of a plasma factor deficient in von Willebrand disease that is necessary for platelet aggregation: relationship to decrease F. VIII procoagulant activity and antigen content. J. Clin. Invest. 52:2708 (1973).
R.W. Wissler, Overview of problems of atherosclerosis. In: Scheinberg P. (ed.): Cerebrovascular disease, p. 56, Raven Press, New York, 1976.
S. Wessler, E.T. Yin, On the antithrombotic action of heparin. Thromb. Diath. Haemorrh. 32:71 (1974).
J.C. White, Electron microscopic studies of platelet secretion. Prog. Haemostas. Thromb. 2:49 (1974).
L.D. Witte, K.L. Kaplan, H.L. Nossel, B.A. Lages, H.J. Weiss, S.G. De Witt, Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ. Res. 42:402 (1978).
N. Woolf, K.C. Carstairs, Infiltration and thrombosis in atherogenes is. A study using immunofluoréscent technique. Am. J. Pathol. 51:373 (1967).
E.T. Yin, L.C. Guidice, S. Wessler, Inhibition of activated factor X-induced platelet aggregation: the role of heparin and the plasma inhibitor to activated factor X. J. Clin. Med. 81:298 (1973).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Avellone, G. et al. (1984). Factor VIII and Antithrombin III in Atherosclerosis Obliterans of the Lower Limbs. In: Strano, A. (eds) Thrombosis and Cardiovascular Disease. Advances in Experimental Medicine and Biology, vol 164. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8616-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8616-2_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8618-6
Online ISBN: 978-1-4684-8616-2
eBook Packages: Springer Book Archive